UPClytics
Overview · Filed: Feb 27, 2025

UPC_APP_10151/2025

METHOD OF TREATING PROLIFERATIVE DISORDERS AND OTHER PATHOLOGICAL CONDITIONS MEDIATED BY BCR-ABL, C-KIT, DDR1, DDR2 OR PDGF-R KINASE ACTIVITY

Procedural & sub-applicationsDocument Access (RoP262)Milan CDGenericCase Closed
Parties

Claimants

  • ALIUD PHARMA GmbH
Reps: Phillip Rektorschek

Respondents

  • Accord Healthcare B.V.
  • Accord Healthcare S.L.U.
  • ACCORD HEALTHCARE LIMITED,
  • Novartis AG
Judges
  • Andrea Postiglione
  • Marije Knijff
  • Oliver Werner
Patents
  • EP2501384
CPC codes: A61P11/06, A61P37/06, A61P43/00, A61P17/00, A61P9/12, A61K31/506, A61P17/06, A61P19/02, A61P25/28, A61P35/00, A61K31/505, C07D239/69

Sector: Organic Chemistry

Outcome
Procedural only
Filed: Feb 27, 2025
First decided: Apr 10, 2025
Language: English
Open on UPC Registry